Gaba Sleep Meta-analysis: What the Evidence Says

Quick Answer

Gaba Sleep Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 2 narrative review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Genetic research further suggests that the heritability of insomnia is higher in women, while neuroimaging studies have revealed functional alterations in brain circuits related to emotional regulation that are strongly associated with insomnia in women. [Kim Hae Ri (2026); evidence level 3]
• By integrating evidence across these dimensions, the present work also aims to provide a multidimensional explanation for women's vulnerability to insomnia and to highlight the need for gender-tailored clinical strategies and future research directions. [Kim Hae Ri (2026); evidence level 3]
• It is known that high medication complexity scores are associated with poor clinical outcomes (-). [Weinhouse Gerald L. (2026); evidence level 3]
• Medication specifically administered to facilitate sleep has had disappointing results in the ICU, contributes to polypharmacy, and may have unintended consequences such as increasing the risk of delirium and falls. [Weinhouse Gerald L. (2026); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For gaba sleep meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Kim Hae Ri (2026). Insomnia and women: exploring vulnerability, impact, and intervention. DOI: 10.1007/s11325-026-03704-0. PMCID: PMC13194315. PMID: 42165944. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is .... https://pmc.ncbi.nlm.nih.gov/articles/PMC13194315/
• Weinhouse Gerald L. (2026). Pharmacotherapy for sleep during critical illness and beyond. DOI: 10.3389/fneur.2026.1814615. PMCID: PMC13160756. PMID: 42131829. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13160756/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.